This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignee: Egenesis, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yinan Kan and Xenograft Innovation.
Introduction
Yinan Kan is an inventor associated with Cambridge, Massachusetts. His work includes patent inventions focused on modifying genes to improve the survival and tolerance of xenografts. The provided information lists 2 patents and identifies eGenesis, Inc. and Hangzhou Qihan Biotechnology Co., Ltd. among the companies where he has worked.
Latest Patents
Kan’s listed patents concern cells, tissues, organs, and animals with one or more modified genes intended to enhance xenograft survival and tolerance. The disclosures also address methods for making and using these modified biological materials and animals.
Career Highlights
Kan’s career includes associations with eGenesis, Inc. and Hangzhou Qihan Biotechnology Co., Ltd. The patent descriptions indicate a focus on genetic modifications that may support the development and use of xenografts.
Collaborations
The provided information names David Angeles Albores and Violette Paragas as Kan’s coworkers. Their shared work is connected to the broader research and development efforts reflected in the xenograft-related patent disclosures.
Conclusion
Yinan Kan’s listed patent work centers on genetic modifications designed to improve xenograft survival and tolerance, alongside methods for producing and using the resulting cells, tissues, organs, and animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile